Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Democrats’ Stumble on Drug Prices Shows Power of Industry

An attempt in the House to take a bite out of drug companies meets resistance.

Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Bill

Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.

Democratic Divisions Flare Over Tax Increases and Drug Pricing

In both the House and the Senate, Democrats are working to resolve their internal differences on a huge social policy measure that will require near-total unity to pass.

Democratic Lawmakers Fracture Over Tax Plans, Drug Prices

Progressive senators pushed back hard on the decision by senior Democrats to focus a $2.1 trillion package of tax increases on income, not wealth.

Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?

Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?

Phony Diagnoses Hide High Rates of Drugging at Nursing Homes

At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.

Phony Diagnoses Hide High Rates of Drugging at Nursing Homes

At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.

Unvaccinated Americans Are 11 Times More Likely to Die of Covid, C.D.C. Reports

Federal health officials released a handful of studies highlighting how effective the shots are at preventing infections, hospitalizations and deaths — even while the highly contagious Delta variant has been dominant.

Biden Administration Goes Bigger on Cutting Drug Prices

The administration endorses a proposal for the government to negotiate on prices for all U.S. purchasers, not just Medicare.